Bristol Myers Squibb stock after-hours at EUR 54.10 on October 2, 2026
Published on 10/02/2026 at 17:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock was at EUR 54.10 after-hours at 5:45 p.m. CEST on October 2, 2026, according to Lang & Schwarz.
Trading in Frankfurt
The Lang & Schwarz quote showed a bid of EUR 53.99 and an ask of EUR 54.21. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.
FDA expands CAMZYOS indication
In a September 30, 2026 release, Bristol Myers Squibb said the U.S. Food and Drug Administration approved CAMZYOS for adults and pediatric patients weighing at least 30 kilograms with symptomatic obstructive hypertrophic cardiomyopathy. The company said the approval was based on results from the Phase 3 SCOUT-HCM trial, which enrolled 44 adolescent patients.
Community grant program announced
In a separate October 1, 2026 release, Bristol Myers Squibb announced a $1 million grant program for nonprofit organizations supporting medically underserved communities in the United States. The company said nominations are due by November 30, 2026.
